PHARMACEUTICAL QUALITY SYSTEM

Pharmaceutical Management Review

A practical guide to Management Review in the pharmaceutical industry, including ICH Q10 expectations, review inputs, quality performance indicators, process and product quality review, management responsibilities, outputs, escalation and continual improvement.

Management Review is a structured process through which senior management evaluates the continuing suitability and effectiveness of the Pharmaceutical Quality System, process performance and product quality.

It provides management with an organized view of quality performance so that significant issues can be escalated, resources can be allocated appropriately and opportunities for continual improvement can be identified.

ICH Q10 PQS Management Review

Senior Management Governance & Oversight

Periodic Formal Review

Improvement Major Review Outcome

Table of Contents

1. What is Management Review? 2. ICH Q10 Basis 3. Objectives of Management Review 4. Management Review Process 5. Management Review Inputs 6. Quality Metrics and Performance Indicators 7. Management Review Outputs 8. Communication and Escalation 9. Management Responsibilities 10. Internal & External Factors 11. Product Lifecycle Application 12. Example Management Review Agenda 13. Documentation and Action Tracking 14. Best Practices 15. Frequently Asked Questions

What is Management Review in Pharmaceuticals?

Pharmaceutical Management Review is a formal evaluation of important information relating to the performance of the Pharmaceutical Quality System, manufacturing processes and product quality.

The review allows senior management to determine whether existing quality systems remain suitable and effective and whether additional actions, resources or improvements are necessary.

Depending on the size and complexity of the pharmaceutical organization, management review may take place through a series of reviews at different management levels, provided that important quality issues can be communicated and escalated effectively.

ICH Q10 and Pharmaceutical Management Review

ICH Q10 identifies management review as an important element of the Pharmaceutical Quality System and places responsibility on senior management for quality-system governance.

Management should evaluate periodic reviews of process performance, product quality and the Pharmaceutical Quality System in order to determine whether systems continue to remain suitable and effective.

Management review therefore connects leadership responsibility with quality monitoring, CAPA, change management, quality objectives and continual improvement.

Objectives of Pharmaceutical Management Review

Evaluate PQS Effectiveness

Determine whether the Pharmaceutical Quality System continues to operate effectively.

Review Product Quality

Evaluate information related to product quality and significant product-quality trends.

Monitor Process Performance

Review whether manufacturing processes remain capable and appropriately controlled.

Review Quality Objectives

Assess progress toward established Pharmaceutical Quality System objectives.

Allocate Resources

Identify situations where personnel, training, facilities or other resources may require adjustment.

Drive Continual Improvement

Identify and prioritize improvements to products, processes and quality-system activities.

Pharmaceutical Management Review Process

A structured management-review process can be represented as a continuous cycle from data collection through implementation and follow-up.

1 Collect Data

2 Analyze Trends

3 Management Review

4 Identify Actions

5 Implement

6 Follow Up

Management Review Inputs

Management review should use relevant information that allows senior management to understand both product-quality performance and the effectiveness of the Pharmaceutical Quality System.

Regulatory Inspections Review regulatory inspection results, observations, findings and relevant commitments made to regulatory authorities.

Audits and Assessments Consider internal audits, external audits and other assessments of the quality system.

Product Quality Complaints Review complaints and customer feedback that may indicate product quality issues or adverse trends.

Recalls Evaluate recalls and other significant product-quality events.

Process Performance Review conclusions from process-performance monitoring and manufacturing trends.

Product Quality Monitoring Review conclusions from product-quality monitoring activities.

CAPA Effectiveness Assess whether corrective and preventive actions have achieved their intended results.

Change Effectiveness Evaluate the effectiveness of implemented process and product changes.

Previous Review Actions Confirm the status and effectiveness of actions assigned during earlier management reviews.

Quality Metrics and Performance Indicators

Performance indicators can help management determine whether quality processes are working effectively and whether quality objectives are being achieved.

Complaints Trend the performance and effectiveness of the complaint-management process.

Deviations Review deviation trends, recurrence and significant quality events.

CAPA Monitor CAPA status, effectiveness and significant recurring issues.

Change Management Evaluate implementation and effectiveness of significant changes.

Outsourced Activities Consider feedback and performance information relating to outsourced activities.

Audits & Risk Assessments Review self-assessment information, trends, audits and relevant risk assessments.

Regulatory Findings Monitor significant regulatory inspection findings and commitments.

Customer Audits Consider relevant observations or findings from customer audits.

Quality Objectives Measure progress toward established pharmaceutical quality objectives.

Typical Review Areas and Management Decisions

Review Area	Management May Evaluate	Possible Action
Complaints	Recurring issues, complaint trends and product impact	Investigation, CAPA or process improvement
Deviations	Frequency, recurring causes and significant events	Root-cause improvement or additional controls
CAPA	Status, effectiveness and overdue actions	Escalation, additional resources or revised actions
Process Performance	Variation, trends and state of control	Process optimization or monitoring changes
Product Quality	Quality trends and significant product issues	Product or process improvement
Regulatory Findings	Inspection observations and commitments	Remediation and management oversight
Resources	Whether current resources adequately support the PQS	Training, staffing or resource realignment

Outputs of Pharmaceutical Management Review

Management review should result in decisions and actions rather than being limited to presentation of quality data.

Process Improvements Actions may be identified to improve manufacturing processes or reduce unwanted variability.

Product Improvements Management may identify opportunities to improve product quality.

Resource Allocation Personnel, equipment, financial or other resources may need to be allocated or realigned.

Training Additional or revised personnel training may be identified.

Knowledge Management Important product and process knowledge should be captured and communicated appropriately.

PQS Improvement Management review may lead to improvements to quality-system processes themselves.

Quality Policy Revision Changes in business or quality-system performance may lead to review or revision of the quality policy.

Quality Objective Revision Quality objectives may be updated where management review identifies a need for new priorities.

Communication and Escalation of Quality Issues

An effective management-review system should include timely communication and escalation of significant quality issues to the appropriate level of senior management.

Serious or potentially important quality issues should not wait for the next routine management-review meeting when immediate escalation is necessary.

The review process should therefore be supported by a clearly defined communication and escalation mechanism.

Responsibilities in Pharmaceutical Management Review

Senior Management Provides governance, reviews significant quality information, makes decisions and ensures appropriate resources are available.

Quality Unit Coordinates or supports quality-data review, trend analysis, escalation and follow-up of management-review actions.

Manufacturing Provides information on process performance, manufacturing trends and improvement activities.

Quality Control Provides relevant laboratory, testing and product-quality information.

Regulatory Affairs Provides information on regulatory commitments, inspections, submissions and relevant regulatory developments.

Other Functions Engineering, supply chain, validation, R&D and other functions may participate according to the topics under review.

Monitoring Internal and External Factors

Management review should not focus only on historical deviations or complaints. Changes inside and outside the organization can also influence the effectiveness of the Pharmaceutical Quality System.

Internal Factors

• Changes in business objectives
• Quality-system performance
• Process and product trends
• Resource needs
• Changes in organizational responsibilities
• Changes in product ownership

External Factors

• Emerging regulations
• New regulatory guidance
• New quality issues
• Regulatory inspection trends
• New technologies and innovations
• Changes affecting the operating environment

Management Review Across the Product Lifecycle

ICH Q10 applies management-review concepts across the pharmaceutical product lifecycle rather than only during routine commercial manufacturing.

1 Pharmaceutical Development

Management review may help evaluate the adequacy of product and process design.

2 Technology Transfer

Review can help determine whether the developed product and process are suitable for manufacturing at commercial scale.

3 Commercial Manufacturing

A structured management-review system supports process control, product quality and continual improvement.

4 Product Discontinuation

Relevant review activities may continue for stability, complaints and products that remain on the market.

Example Pharmaceutical Management Review Agenda

The exact agenda should reflect the company's products, processes, risks and Pharmaceutical Quality System. A practical agenda may include the following review areas.

1. Status of previous management-review actions

2. Progress against quality objectives

3. Product quality and process-performance trends

4. Complaints and recalls

5. Deviations and nonconformances

6. CAPA status and effectiveness

7. Change-management performance

8. Internal and external audit findings

9. Regulatory inspection findings and commitments

10. Outsourced activities and supplier-related feedback

11. Resource and training requirements

12. Improvement opportunities and management decisions

Management Review Documentation and Action Tracking

Management-review results should be documented and communicated appropriately. Documentation should make it possible to understand what was reviewed, what decisions were made and who is responsible for follow-up.

A practical management-review record may include:

• Date and review period
• Participants
• Agenda and data reviewed
• Important trends and conclusions
• Decisions taken
• Assigned actions
• Responsible person or department
• Target completion date
• Escalation requirements
• Status of previous actions
• Evidence of action closure or effectiveness review

Example Action Tracker

Action	Responsibility	Target Date	Status	Effectiveness / Follow-up
Describe required improvement	Assigned department/person	Defined target date	Open / In Progress / Closed	Record follow-up or effectiveness conclusion

Best Practices for Effective Pharmaceutical Management Review

Use Trend Data Review trends rather than relying only on isolated quality events.

Focus on Decisions Management review should lead to clear conclusions and actions.

Escalate Significant Issues Important quality risks should be communicated promptly to the appropriate management level.

Track Previous Actions Open management-review actions should remain visible until appropriately completed.

Use Meaningful Metrics Performance indicators should help management understand quality performance rather than simply increase the volume of data.

Review Effectiveness Where appropriate, confirm that actions taken actually achieved the intended improvement.

Include Cross-Functional Input Relevant departments should contribute information required for a complete understanding of quality performance.

Promote Continual Improvement Use management review as a mechanism for improving products, processes and the Pharmaceutical Quality System.

Key Takeaway

Pharmaceutical Management Review connects senior management with the actual performance of the Pharmaceutical Quality System. A strong review process brings together product-quality information, process performance, complaints, CAPA, changes, audits, regulatory findings, quality objectives and other performance indicators so management can make informed decisions, allocate resources, escalate significant risks and drive continual improvement.

Frequently Asked Questions About Pharmaceutical Management Review

1. What is Management Review in the pharmaceutical industry?

Management Review is a formal process through which management evaluates process performance, product quality and the continuing suitability and effectiveness of the Pharmaceutical Quality System.

2. Which ICH guideline addresses Pharmaceutical Management Review?

ICH Q10 Pharmaceutical Quality System addresses management responsibility, management review of process performance and product quality, and periodic review of the Pharmaceutical Quality System.

3. Who is responsible for Management Review?

Senior management is responsible for governance of the Pharmaceutical Quality System through management review, with relevant functions providing the information needed for review.

4. What should be reviewed during a pharmaceutical Management Review?

Relevant information may include process performance, product quality, complaints, recalls, CAPA, changes, audit findings, regulatory inspections, quality objectives, outsourced activities and previous management-review actions.

5. What are the outputs of Management Review?

Outputs may include process and product improvements, improvements to the Pharmaceutical Quality System, resource or training decisions, revisions to quality objectives or policies, and actions requiring communication or escalation.

6. How often should Management Review be conducted?

ICH Q10 describes management review as a periodic formal process. The organization should establish an appropriate review approach considering its quality system, complexity, risks and management structure.

7. Is Management Review the same as Product Quality Review?

No. Product-quality review information can be an important input into Management Review, but Management Review has a broader focus that also covers the effectiveness of the Pharmaceutical Quality System, resources, quality objectives and improvement needs.

8. Why are previous Management Review actions reviewed again?

Reviewing previous actions helps management determine whether assigned actions were completed and whether they achieved the intended result.

Primary reference: ICH Q10 Pharmaceutical Quality System, including sections covering Management Responsibility, Management Review of Process Performance and Product Quality, Management Review of the Pharmaceutical Quality System, monitoring of internal and external factors, and management review outcomes.